Apr-07-19
The RejunvenAir system from CSA Medical treats COPD by delivering targeted liquid nitrogen to the lungs.
Recently awarded Breakthrough Device designation and an Investigational Device Exemption from the FDA, the RejuvenAir destroys the mucus-creating goblet cells on the epithelial layer of the lungs with targeted treatments of liquid nitrogen. Because the extracellular matrix of the lungs is not damaged, new cells can quickly regrow in the treated area.
More Info about this Invention:
[
PRNEWSWIRE.COM]
[
CSAMEDICAL.COM]
Add Your Comment